Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merz North America Inc.

Division of Merz GmbH & Co. KGaA
www.merzusa.com

Latest From Merz North America Inc.

Allergan Aesthetic Medicines Head Moatazedi Moves To Emerging Competitor Evolus

David Moatazedi is leaving behind the aesthetic medicines group at Allergan to run the newly public, aesthetics-only firm Evolus, where US and EU approval of the Botox competitor DWP-450 (prabotulinumtoxinA) is imminent and the new CEO says the opportunity is unparalleled.

Leadership Aesthetics

Valeant On Track With Debt-Reduction Goals, But Will It Be Enough?

The troubled firm has pushed back its greatest debt burden until 2020, but new products are unlikely to fill sales gap. Valeant says its GI unit is showing positive signs and that a restructuring of the derm commercial unit is nearing completion.

Sales & Earnings Financing

Guided Therapy Systems Keeps Options Open On Tissue Regen Device

Guided Therapy Systems CEO Michael Slayton, PhD, has a history of breaking innovative medical technology, with a primary focus on diagnostic and therapeutic ultrasound applications. He tells In Vivo about the 22-year engineering journey that has led him and the company he founded to the cusp of market launch of a non-invasive tissue regeneration device for musculoskeletal injuries.

Medical Device Leadership

Deals Shaping the Medical Industry, April 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2016.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merz GmbH & Co. KGaA
  • Senior Management
  • Bill Humphries, Pres. & CEO
    Alana Sine, CFO
    David Dobrowski, VP, Head, North American R&D
  • Contact Info
  • Merz North America Inc.
    Phone: (919) 582-8000
    6501 Six Forks Rd.
    Raleigh, NC 27615
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register